# Eric Feinstein

> Eric Feinstein is the President and CEO of Clarapath, a Hawthorne, New York medical robotics company automating one of the last manual corners of the pathology lab: cutting and mounting tissue for diagnosis. Under his leadership Clarapath built SectionStar, an FDA-registered robotic microtomy platform, acquired the digital-pathology software firm Crosscope, forged a research collaboration with Mayo Clinic, and closed a $36M Series B in 2024. A former medical-device investor and operator with an MBA from Cornell, Feinstein frames the histology lab as a Lean Six Sigma manufacturing operation and pitches a broader vision he calls Laboratory 2.0.

- **Role:** President & CEO at Clarapath
- **Organizations:** Clarapath, Northwell Ventures, RGP, BSV Consulting Group, Ampersand Capital Partners, Landmark Partners
- **Nationality:** American
- **Education:** MBA, Cornell University, Johnson Graduate School of Management, BA, Trinity College, Hartford
- **Known for:** Led Clarapath's development of SectionStar, an FDA-registered robotic microtomy platform, Closed a $36M Series B round in 2024 to modernize 150-year-old laboratory processes, Directed the 2023 acquisition of digital-pathology AI company Crosscope

## Career timeline

- **—** — Structured investment opportunities at Landmark Partners and Ampersand Capital Partners
- **—** — Principal at BSV Consulting Group
- **—** — Director of the Northeast Transaction Advisory and M&A group at RGP
- **—** — Investment Director at Northwell Ventures
- **2014** — Clarapath founded, growing out of Dr. Partha Mitra's neuroanatomy research at Cold Spring Harbor Laboratory
- **2022** — Clarapath passes first round of certifications and expands its Hawthorne, NY headquarters
- **2023** — Clarapath acquires Crosscope, adding AI-powered digital pathology software
- **2024** — Clarapath forms research collaboration with Mayo Clinic and closes a $36M Series B

## Achievements

- Led Clarapath's development of SectionStar, an FDA-registered robotic microtomy platform
- Closed a $36M Series B round in 2024 to modernize 150-year-old laboratory processes
- Directed the 2023 acquisition of digital-pathology AI company Crosscope
- Established a strategic research collaboration between Clarapath and Mayo Clinic
- Named to The Business Council of Westchester's 40 Under 40 Rising Stars

## Latest updates

- **2024-07** — Clarapath closed a $36M Series B round to accelerate the rollout of SectionStar.
- **2024-04** — Clarapath announced a strategic collaboration with Mayo Clinic to advance pathology tissue processing.

## Links

- Website: https://clarapath.com
- LinkedIn: http://www.linkedin.com/in/eric-feinstein-7b35257

---

Profile page: https://yespress.io/eric-feinstein
Published by YesPress — https://yespress.io
Last updated: 2026-07-17